Cargando…

Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus

BACKGROUND: We aimed to investigate the long-term effect of metformin on the blood glucose control in non-obese patients with type 2 diabetes mellitus. METHODS: A retrospective study was performed in 213 patients with type 2 diabetes mellitus under the administration of metformin for more than one y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Hiroyuki, Ishida, Hidenori, Takeuchi, Yuichiro, Antoku, Shinichi, Abe, Mariko, Mifune, Mizuo, Togane, Michiko
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991324/ https://www.ncbi.nlm.nih.gov/pubmed/21070671 http://dx.doi.org/10.1186/1743-7075-7-83

Ejemplares similares

Mild anemia is frequent and associated with micro‐ and macroangiopathies in patients with type 2 diabetes mellitus
por: Ito, Hiroyuki, et al.
Publicado: (2010)

Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus
por: Ito, Hiroyuki, et al.
Publicado: (2011)

The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study
por: Ito, Hiroyuki, et al.
Publicado: (2010)

Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational study
por: Ito, Hiroyuki, et al.
Publicado: (2012)

Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus
por: Ito, Hiroyuki, et al.
Publicado: (2014)

Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study
por: Ito, Hiroyuki, et al.
Publicado: (2016)

The Prevalence of the Risk Factors for Atherosclerosis among Type 2 Diabetic Patients Is Greater in the Progressive Stages of Chronic Kidney Disease
por: Ito, Hiroyuki, et al.
Publicado: (2013)

Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis
por: Ito, Hiroyuki, et al.
Publicado: (2013)

Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013
por: Ito, Hiroyuki, et al.
Publicado: (2016)

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2017)

Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease
por: Ito, Hiroyuki, et al.
Publicado: (2015)

Relationship Between the Effect of Roxadustat and Comorbid Diabetes in Non-dialyzed Chronic Kidney Disease Patients: A Retrospective Observational Study
por: Ito, Hiroyuki, et al.
Publicado: (2023)

Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin
por: Ito, Hiroyuki, et al.
Publicado: (2023)

Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation
por: Ito, Hiroyuki, et al.
Publicado: (2021)

A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation study
por: Ito, Hiroyuki, et al.
Publicado: (2018)

Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2019)

Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study
por: Ito, Hiroyuki, et al.
Publicado: (2022)

Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin
por: Hamano, Kunihisa, et al.
Publicado: (2019)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang, Qi, et al.
Publicado: (2020)

Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
por: Sales, Willian Barbosa, et al.
Publicado: (2018)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice
por: Zhou, Qiyun, et al.
Publicado: (2022)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Long-term effects of metformin use in gestational diabetes mellitus on offspring health
por: Roy, Ayan, et al.
Publicado: (2021)

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

FRI649 ADMIRE: Assessing Dapagliflozin And Metformin As An Initial Regimen In Diabetes Mellitus For Enhanced Glucose Control
por: Phadke, Dr Uday, et al.
Publicado: (2023)

Erratum for Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II
por: Izutsu, Takuma, et al.
Publicado: (2021)

Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II
por: Izutsu, Takuma, et al.
Publicado: (2020)

Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus
por: Ito, Yuichiro, et al.
Publicado: (2019)

Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus: A meta-analysis
por: Li, Jian, et al.
Publicado: (2017)

Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
por: Raparelli, Valeria, et al.
Publicado: (2020)

Effect of metformin on the epigenetic age of peripheral blood in patients with diabetes mellitus
por: Li, Man, et al.
Publicado: (2022)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Jeon, Ja Young, et al.
Publicado: (2021)

Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021)

Lifestyle modification and metformin as long-term treatment options for obese adolescents: study protocol
por: Wilson, A Justine, et al.
Publicado: (2009)

Effects of dosage and dosing frequency on the efficacy and safety of high‐dose metformin in Japanese patients with type 2 diabetes mellitus
por: Kanto, Kousei, et al.
Publicado: (2017)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v0bluqi3l83t6sjnl2n8tkaq1b